Roxithromycin, a macrolide antibiotic, is used in the treatment of acne vulgaris, although there have been no reports on its concentration in lesions when administered orally. We investigated the concentration of roxithromycin in acne vulgaris lesions in five patients who received 150 mg roxithromycin orally twice daily for 2 weeks. The mean concentration of roxithromycin in the lesions was 0.54 μg/ml. These results suggest that roxithromycin accumulates at therapeutic levels in the pilosebaceous system.
AkamatsuHAsadaY: Acne: clinical classification and treatment of acne vulgaris. In: Manual of Treatment of Dermal Infections (KukitaAHaradaS, eds). Tokyo: Rinshou Iyaku, 1999; pp13–18
2.
HokamaH: The mechanism of action of TC antibiotics against acne vulgaris (in Japanese, English abstract). J Tokyo Med Coll1984; 42: 619–632
3.
AkamatsuHNishijimaSAkamatsuMKurokawaIAsadaY: Clinical evaluation of roxithromycin in patients with acne. J Int Med Res1996; 24: 109–114
4.
ArataJ: A multicenter clinical trial of RU-965 (roxithromycin) in the management of acne (in Japanese). Jpn J Dermatol1997; 59: 444–450
5.
YamamotoTShirotsukaMShiroishiH: Microbiological assay for RU 28965 in body fluids (in Japanese, English abstract). Chemotherapy1988; 36 (Suppl 14): 131–137
6.
AkamatsuHAsadaY: Acne: mechanism of onset of acne vulgaris. In: Manual of Treatment of Dermal Infections (KukitaAHaradaS, eds). Tokyo: Rinshou Iyaku, 1999; pp7–12
7.
NakagawaKKobayashiHFukaiK: Skin tissue penetration of roxithromycin and its clinical efficacy in the treatment of bacterial skin disorders. Skin Research1993; 35: 668–676
8.
NishijimaSAkamatsuHAkamatsuMKurokawaIAsadaY: The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne. J Dermatol1994; 21: 166–171
9.
AkamatsuHNishijimaSAkamatsuMKurokawaISasakiHAsadaY: The effect of roxithromycin on the generation of reactive oxygen species in vitro. J Int Med Res1996; 24: 27–32
